Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: A solid biodegradable leuprorelin implant versus other formulations

Axel S. Merseburger, Thomas Björk, James Whitehouse, Davide Meani*

*Corresponding author for this work
8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: A solid biodegradable leuprorelin implant versus other formulations'. Together they form a unique fingerprint.

Medicine & Life Sciences